Back
Calidi Biotherapeutics Stock Price Chart
Sponsored
CLDI
Sponsored
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
52
CLDI
Calidi Biotherapeutics
Last Price:
1.91
Seasonality Move:
-23.28%
7 Day Trial
ALL ACCESS PASS
$
7
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE- The current trend is moderately bearish and CLDI is experiencing selling pressure, which indicates risk of future bearish movement.
Calidi Biotherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.01 | Sell |
20-day SMA: | 2.16 | Sell |
50-day SMA: | 1.59 | Buy |
200-day SMA: | 2.4 | Sell |
8-day EMA: | 1.99 | Sell |
20-day EMA: | 1.97 | Sell |
50-day EMA: | 1.76 | Buy |
200-day EMA: | 7.49 | Sell |
Calidi Biotherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.08 | Buy |
Relative Strength Index (14 RSI): | 49.59 | Sell |
Chaikin Money Flow: | -381698 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.72 - 2.42) | Sell |
Bollinger Bands (100): | (1.03 - 1.91) | Buy |
Calidi Biotherapeutics Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Calidi Biotherapeutics Stock
Is Calidi Biotherapeutics Stock a Buy?
- Calidi Biotherapeutics share price is 1.90 while CLDI 8-day simple moving average is 2.01, which is a Sell signal.
- The stock price of CLDI is 1.90 while Calidi Biotherapeutics 20-day SMA is 2.16, which makes it a Sell.
- Calidi Biotherapeutics 50-day simple moving average is 1.59 while CLDI share price is 1.90, making it a Buy technically.
- CLDI stock price is 1.90 and Calidi Biotherapeutics 200-day simple moving average is 2.40, creating a Sell signal.
CLDI Technical Analysis vs Fundamental Analysis
Buy
52
Calidi Biotherapeutics (CLDI)
is a Buy
Is Calidi Biotherapeutics a Buy or a Sell?
-
Calidi Biotherapeutics stock is rated a Buy
The current Calidi Biotherapeutics [CLDI] share price is $1.90. The Score for CLDI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Calidi Biotherapeutics Stock Info
Market Cap:
33.28M
Price in USD:
1.90
Share Volume:
667.97K
Calidi Biotherapeutics 52-Week Range
52-Week High:
24.00
52-Week Low:
0.73
Buy
52
Calidi Biotherapeutics (CLDI)
is a Buy
Calidi Biotherapeutics Share Price Forecast
-
What is the Calidi Biotherapeutics stock price today?
The Calidi Biotherapeutics stock price is 1.90 USD today. -
Will CLDI stock go up or go down?
Calidi Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Calidi Biotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Calidi Biotherapeutics is not overvalued.
Is Calidi Biotherapeutics Stock a Buy?
- Calidi Biotherapeutics share price is 1.90 while CLDI 8-day exponential moving average is 1.99, which is a Sell signal.
- The stock price of CLDI is 1.90 while Calidi Biotherapeutics 20-day EMA is 1.97, which makes it a Sell.
- Calidi Biotherapeutics 50-day exponential moving average is 1.76 while CLDI share price is 1.90, making it a Buy technically.
- CLDI stock price is 1.90 and Calidi Biotherapeutics 200-day simple moving average is 7.49, creating a Sell signal.
Fundamental Analysis of Calidi Biotherapeutics
Is Calidi Biotherapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.72 per share, and an increase next year of $0.29 per share.
Technical Analysis of Calidi Biotherapeutics
Should I short Calidi Biotherapeutics stock?
- CLDI Moving Average Covergence Divergence (MACD) indicator is 0.08, suggesting Calidi Biotherapeutics is a Buy
- Calidi Biotherapeutics Relative Strength Index (RSI) is 49.59, which suggest Calidi Biotherapeutics is oversold
- The Bollinger Bands (25) for Calidi Biotherapeutics is (1.72 - 2.42), which suggest Calidi Biotherapeutics is a Buy
- The Bollinger Bands (100) for Calidi Biotherapeutics is (1.03 - 1.91), which suggest Calidi Biotherapeutics is a Buy
* Calidi Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.